Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-16-015273
Filing Date
2016-03-04
Accepted
2016-03-04 16:20:05
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1640294
2 GRAPHIC g142578g06i09.jpg GRAPHIC 161079
3 GRAPHIC g142578g06l57.jpg GRAPHIC 173371
4 GRAPHIC g142578g10q14.jpg GRAPHIC 50865
5 GRAPHIC g142578g15c64.jpg GRAPHIC 44883
6 GRAPHIC g142578g19t80.jpg GRAPHIC 62177
7 GRAPHIC g142578g20t64.jpg GRAPHIC 134609
8 GRAPHIC g142578g21p99.jpg GRAPHIC 91078
9 GRAPHIC g142578g21v14.jpg GRAPHIC 82516
10 GRAPHIC g142578g30w28.jpg GRAPHIC 71161
11 GRAPHIC g142578g54a00.jpg GRAPHIC 107626
12 GRAPHIC g142578g58g66.jpg GRAPHIC 78788
13 GRAPHIC g142578g58m29.jpg GRAPHIC 59459
14 GRAPHIC g142578g66e76.jpg GRAPHIC 46951
15 GRAPHIC g142578g76r88.jpg GRAPHIC 129227
16 GRAPHIC g142578g87e13.jpg GRAPHIC 44888
17 GRAPHIC g142578g89m59.jpg GRAPHIC 31751
  Complete submission text file 0000950123-16-015273.txt   3520747
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01276 | Film No.: 161485484
SIC: 2834 Pharmaceutical Preparations